Evaluation of Initial Metastatic Tumor Location and Radiation Response to Determine Outcomes in Patients Who Received Combination Stereotactic Body Radiotherapy and Immunotherapy for NSCLC.

Liver metastases present at diagnosis in metastatic NSCLC correlate with worse PFS. Treated metastases control rates also correlate with OS. These metrics may help predict outcomes and inform whether additional aggressive therapy is required for patients with metastatic NSCLC.